SUI DeSci Agent, a platform built to empower retail audiences to infuse in longevity research breakthroughs, has announced the launch of its project as DeSci’s momentum continues to grow.
According to an official announcement today, the platform’s launch follows plans to allow retail users to enjoy exclusive and democratized access to longevity research. With this development, SUI DeSci Agents is a leading project in the rapidly evolving decentralized science (DeSci)’s space.
Following its design, SUI DeSci Agents is committed to launching DeSci assets, growing their audience with AI agents, and creating liquidity through advanced mechanics inspired by pump.fun.
While it has made a remarkable entry into the DeSci ecosystem, this launch comes with the introduction of its token $DESCI.With this token, SUI DeSci promises to offer users unique features, including tokenized compounds, pluggable AI agents, layer-2 liquidity mechanics, and AI-powered B2C products.
These features allow users to bet on the potential of longevity compounds like Epitalon and Rapamycin (the first compounds to be launched) by reviewing their scientific data and statistics. Furthermore, the project pairs LLM-trained AI agents with longevity compounds and promotes them 24/7 across social platforms to ensure efficient outreach.
Notably, the platform has embarked on a mission to create a robust liquidity ecosystem tailored for DeSci while driving organic growth and supporting the ecosystem.
DeSci’s Potential as the Next Major Trend For 2025
Decentralized Science (DeSci) has continued to emerge rapidly following its mission to curtail systemic inefficiencies in traditional scientific research, such as bureaucratic funding processes, underfunded breakthrough opportunities, and limited retail access to longevity investments.
The growing momentum surrounding DeSci has been spurred by notable support from key leaders such as Vitalik Buterin, who emphasized the transformative potential of DeSci projects at the recent Devcon event.
Moreover, the founder of Coinbase, Brian Armstrong, has also disclosed support for ResearchHub to drive open scientific collaboration. Another notable support came from A16Z, which led a $5M funding round for AminoChain, a decentralized biosample marketplace.
Also, Pfizer Ventures participated in a $4.1M funding round of VitaDAO, a project focusing on raising funds for research that expands human lifespan.
As the decentralized science (DeSci) sector eyes further growth in 2025, SUI DeSci Agents is looking to develop a platform where the retail audience can invest in tokenized longevity compounds.
The project also revealed plans to implement AI-powered B2C wellness tools to help SUI Desci Agents onboard more users into the ecosystem.